Literature DB >> 34433028

The bacteriophage LUZ24 "Igy" peptide inhibits the Pseudomonas DNA gyrase.

Jeroen De Smet1, Jeroen Wagemans1, Maarten Boon1, Pieter-Jan Ceyssens1, Marleen Voet1, Jean-Paul Noben2, Julia Andreeva3, Dmitry Ghilarov3, Konstantin Severinov4, Rob Lavigne5.   

Abstract

The bacterial DNA gyrase complex (GyrA/GyrB) plays a crucial role during DNA replication and serves as a target for multiple antibiotics, including the fluoroquinolones. Despite it being a valuable antibiotics target, resistance emergence by pathogens including Pseudomonas aeruginosa are proving problematic. Here, we describe Igy, a peptide inhibitor of gyrase, encoded by Pseudomonas bacteriophage LUZ24 and other members of the Bruynoghevirus genus. Igy (5.6 kDa) inhibits in vitro gyrase activity and interacts with the P. aeruginosa GyrB subunit, possibly by DNA mimicry, as indicated by a de novo model of the peptide and mutagenesis. In vivo, overproduction of Igy blocks DNA replication and leads to cell death also in fluoroquinolone-resistant bacterial isolates. These data highlight the potential of discovering phage-inspired leads for antibiotics development, supported by co-evolution, as Igy may serve as a scaffold for small molecule mimicry to target the DNA gyrase complex, without cross-resistance to existing molecules.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA gyrase; ORFan; Pseudomonas aeruginosa; bacteriophage; drug discovery

Mesh:

Substances:

Year:  2021        PMID: 34433028     DOI: 10.1016/j.celrep.2021.109567

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  2 in total

1.  Complete Genome Sequence of Pseudomonas aeruginosa Bacteriophage vB_PaeP_PaCe.

Authors:  Ryan Cook; Taylor Darby; Dwayne R Roach
Journal:  Microbiol Resour Announc       Date:  2022-07-18

2.  Ciprofloxacin-Loaded Titanium Nanotubes Coated with Chitosan: A Promising Formulation with Sustained Release and Enhanced Antibacterial Properties.

Authors:  Soada Asadi; Bardia Mortezagholi; Alireza Hadizadeh; Vitaliy Borisov; Mohammad Javed Ansari; Hasan Shaker Majdi; Azizakhon Nishonova; Hossein Adelnia; Bahareh Farasati Far; Chaiyavat Chaiyasut
Journal:  Pharmaceutics       Date:  2022-06-27       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.